ATE242638T1 - Verwendung einer zusammensetzung enthaltend sojaprotein, diätfasern und phytoestrogen zur vorbeugung und/oder behandlung von lungenerkrankungen - Google Patents

Verwendung einer zusammensetzung enthaltend sojaprotein, diätfasern und phytoestrogen zur vorbeugung und/oder behandlung von lungenerkrankungen

Info

Publication number
ATE242638T1
ATE242638T1 AT99972540T AT99972540T ATE242638T1 AT E242638 T1 ATE242638 T1 AT E242638T1 AT 99972540 T AT99972540 T AT 99972540T AT 99972540 T AT99972540 T AT 99972540T AT E242638 T1 ATE242638 T1 AT E242638T1
Authority
AT
Austria
Prior art keywords
soy protein
composition
dietary fibers
phytoestrogen
prevention
Prior art date
Application number
AT99972540T
Other languages
English (en)
Inventor
Lars Henrik Hoie
Original Assignee
Nutri Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutri Pharma As filed Critical Nutri Pharma As
Application granted granted Critical
Publication of ATE242638T1 publication Critical patent/ATE242638T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/185—Vegetable proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Botany (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT99972540T 1998-11-25 1999-11-25 Verwendung einer zusammensetzung enthaltend sojaprotein, diätfasern und phytoestrogen zur vorbeugung und/oder behandlung von lungenerkrankungen ATE242638T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199801557 1998-11-25
PCT/IB1999/001997 WO2000030664A1 (en) 1998-11-25 1999-11-25 Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of pulmonary diseases

Publications (1)

Publication Number Publication Date
ATE242638T1 true ATE242638T1 (de) 2003-06-15

Family

ID=8106042

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99972540T ATE242638T1 (de) 1998-11-25 1999-11-25 Verwendung einer zusammensetzung enthaltend sojaprotein, diätfasern und phytoestrogen zur vorbeugung und/oder behandlung von lungenerkrankungen

Country Status (10)

Country Link
US (1) US6509043B1 (de)
EP (1) EP1133307B1 (de)
JP (1) JP2002530346A (de)
AT (1) ATE242638T1 (de)
AU (1) AU1404600A (de)
BR (1) BR9915689A (de)
CA (1) CA2352338A1 (de)
DE (1) DE69908809D1 (de)
HK (1) HK1041634A1 (de)
WO (1) WO2000030664A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU767245B2 (en) * 1998-11-25 2003-11-06 Nutri Pharma Asa Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of cardiovascular diseases
US6592910B1 (en) 1999-04-20 2003-07-15 Board Of Trustees, Southern Illinois University Methods of treating clinical diseases with isoflavones
IL152175A (en) 2000-04-14 2005-08-31 Mars Inc Compositions and methods for improving vascular health
US6559177B2 (en) 2001-04-19 2003-05-06 Wyeth 5, 11-Dioxa-benzo[b]fluoren-10-one and 5-oxa-11-thia-benzo[b]fluoren-10-ones as estrogenic agents
US6589980B2 (en) 2001-05-17 2003-07-08 Wyeth Substituted 10,11-benzo[b]fluoren-10-ones as estrogenic agents
US20040234631A1 (en) * 2001-07-03 2004-11-25 Hoie Lars Henrik Composition comprising soy and use thereof in the provention and/or treatment of various diseases
AU2003206050A1 (en) * 2002-02-22 2003-09-09 Nutri Pharma Asa Food products comprising soy protein
EP1480525A2 (de) * 2002-02-23 2004-12-01 Nutri Pharma ASA Neue sojaproteinprodukte
WO2004009035A2 (en) 2002-07-24 2004-01-29 Children's Hospital Medical Center Compositions and products containing enantiomeric equol, and methods for their making
US8668914B2 (en) * 2002-07-24 2014-03-11 Brigham Young University Use of equol for treating skin diseases
US8580846B2 (en) 2002-10-29 2013-11-12 Brigham Young University Use of equol for ameliorating or preventing neuropsychiatric and neurodegenerative diseases or disorders
EP1569636B1 (de) 2002-10-29 2017-12-13 Colorado State University Research Foundation Verwendung von equol zur behandlung von androgenvermittelten erkrankungen
AU2005239984B2 (en) * 2002-10-29 2010-06-03 Brigham Young University Use of equol for treating skin diseases
CA2545788A1 (en) * 2003-11-13 2005-06-02 Galileo Pharmaceuticals, Inc. Plant-derived protein extract compositions and methods
US20050261197A1 (en) * 2004-05-19 2005-11-24 Henry Aoki Coffee bean extract, method of extraction and composition containing the same
US20060280840A1 (en) * 2005-05-24 2006-12-14 Robertson Marion G Universal protein formulation meeting multiple dietary needs for optimal health and enhancing the human immune system
US20160015776A1 (en) 2013-03-15 2016-01-21 Soy Labs, Llc Products and methods using lunasin enriched soy extract mixtures to reduce free fatty acid levels, increase leptin levels and increase adiponectin levels in plasma
WO2015053810A1 (en) * 2013-10-11 2015-04-16 Rajakaruna Uppala Food additives and methods of making and using same
WO2021064107A1 (en) 2019-10-02 2021-04-08 Norvia Nutrition Ltd. Composition comprising soy and use thereof in the prevention and/or treatment of microvascular or lipoprotein related diseases, microcardiovascular diseases, atherosclerosis, hypertension, and in patients with such cardiovascular disorders suffering from alzheimer and dementia, overweight and obesity, type 2 diabetes, asthma and other disorders

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2395288A1 (fr) * 1977-06-23 1979-01-19 Ppn Nouvelles compositions therapeutiques destinees notamment a la prevention et au traitement des maladies de plethore
US4557927A (en) 1983-03-10 1985-12-10 Kabushiki Kaisha Hoyashibara Food products and process for producing same
FR2543550B1 (fr) 1983-04-01 1985-08-09 Cortial Nouveaux derives de la tetrahydroxy-3', 4',5,7 flavone, leur methode de preparation et leur emploi therapeutique
JPS62201882A (ja) 1985-11-18 1987-09-05 Yamanouchi Pharmaceut Co Ltd イソフラボン誘導体
US4818558A (en) 1987-08-04 1989-04-04 Worthington Foods, Inc. Fiber/tofu food product and method for making the same
JPH0714927B2 (ja) 1988-04-06 1995-02-22 キッコーマン株式会社 イソフラボン化合物の製造法
FR2684301B1 (fr) * 1991-12-02 1995-03-24 Synthelabo Composition pharmaceutique contenant de l'egf pour le traitement des pathologies bronchopulmonaires.
US5223285A (en) * 1992-03-31 1993-06-29 Abbott Laboratories Nutritional product for pulmonary patients
USRE40792E1 (en) 1992-05-19 2009-06-23 Novogen Research Pty Ltd Health supplements containing phyto-oestrogens, analogues or metabolites thereof
DK171752B1 (da) 1992-07-06 1997-05-12 Birgitte Stilling Brødlignende produkt med blodsukkersænkende virkning til diabetikere samt pulverformig blanding til anvendelse ved fremstilling deraf
CA2160371A1 (en) 1993-04-16 1994-10-27 The Trustees Of Tufts College Method for treatment of menopausal and premenstrual symptoms
JP3777390B2 (ja) 1993-10-12 2006-05-24 アーチャー ダニエルズ ミッドランド カンパニー アグルコンイソフラボン濃縮植物タンパク質抽出物及び単離物並びにその製造方法
CA2173999C (en) 1993-10-12 2008-09-09 Jerome L. Shen An aglucone isoflavone enriched vegetable protein whey, whey protein, and process for producing
US5320949A (en) 1993-10-12 1994-06-14 Protein Technologies International, Inc. Process for producing aglucone isoflavone enriched vegetable protein fiber
DE69429673T3 (de) 1993-10-12 2007-08-23 Archer Daniels Midland Co., Decatur Ein aglukon isoflavon angereichertes pflanzenproteinkonzentrat und ein verfahren zu dessen herstellung
US6140469A (en) 1993-10-12 2000-10-31 Protein Technologies International, Inc. Protein isolate having an increased level of isoflavone compounds and process for producing the same
US5589182A (en) 1993-12-06 1996-12-31 Tashiro; Renki Compositions and method of treating cardio-, cerebro-vascular and alzheimer's diseases and depression
US5463283A (en) 1994-05-24 1995-10-31 Bkl, Inc. Drive circuit for electroluminescent lamp
WO1996010341A1 (en) 1994-10-03 1996-04-11 Schouten Industries B.V. Food and health products
US5516528A (en) 1995-01-13 1996-05-14 Wake Forest University Dietary phytoestrogen in estrogen replacement therapy
IL115110A (en) 1995-08-30 1997-08-14 Chajuss Daniel Soy molasses
CA2192725C (en) * 1995-12-28 2004-04-20 Kenji Tsujihara Camptothecin derivatives
PT902624E (pt) * 1996-02-29 2001-04-30 Nutri Pharma As Composicao e sua utilizacao como suplemento alimentar ou para diminuir os lipidos no soro
US5702752A (en) 1996-03-13 1997-12-30 Archer Daniels Midland Company Production of isoflavone enriched fractions from soy protein extracts
PT906029E (pt) * 1996-04-09 2002-11-29 Du Pont Produto de proteina de soja enriquecido em isoflavona e metodo para o seu fabrico
WO1998003084A1 (en) 1996-07-18 1998-01-29 Nutricor, Inc. Nutritious food preparations and methods for making them
US5654011A (en) 1996-07-30 1997-08-05 Energetics, Inc. Dietary supplements
US5726034A (en) 1996-09-06 1998-03-10 Protein Technologies International, Inc. Aglucone isoflavone enriched vegetable protein extract and protein material, and high genistein and daidzein content materials and process for producing the same
AU3218697A (en) 1997-01-21 1998-08-07 Minnesota Mining And Manufacturing Company Tubing for an ink delivery system
WO1998035699A1 (en) * 1997-02-12 1998-08-20 Nutri Pharma Asa Use of a combination of an anti-smoking composition and a dietary composition in smoking cessation
US5948814A (en) * 1997-02-20 1999-09-07 The Curators Of The University Of Missouri Genistein for the treatment of cystic fibrosis
EP1310173B2 (de) 1997-06-23 2014-12-31 Société des Produits Nestlé S.A. Zusammensetzung zur Ernährung von Diabetikern
US5855892A (en) * 1997-09-19 1999-01-05 Potter; Susan M. Method for decreasing LDL-cholesterol concentration and increasing HDL-cholesterol concentration in the blood to reduce the risk of atherosclerosis and vascular disease

Also Published As

Publication number Publication date
CA2352338A1 (en) 2000-06-02
WO2000030664A1 (en) 2000-06-02
EP1133307B1 (de) 2003-06-11
AU1404600A (en) 2000-06-13
DE69908809D1 (de) 2003-07-17
EP1133307A1 (de) 2001-09-19
JP2002530346A (ja) 2002-09-17
US6509043B1 (en) 2003-01-21
HK1041634A1 (zh) 2002-07-19
BR9915689A (pt) 2002-10-08

Similar Documents

Publication Publication Date Title
DE69914947D1 (de) Zusammensetzung enthaltend sojaprotein, diätfasern und phytoestrogen sowie ihre verwendung zur vorbeugung und/oder behandlung von typ ii diabetes, des metabolischen syndroms und assozierten kardiovaskulären erkrankungen
ATE242638T1 (de) Verwendung einer zusammensetzung enthaltend sojaprotein, diätfasern und phytoestrogen zur vorbeugung und/oder behandlung von lungenerkrankungen
ATE253925T1 (de) Zusammensetzung enthaltend sojaprotein, diätfasern und phytoestrogen sowie ihre verwendung zur vorbeugung und/oder behandlung von kardiovaskulären erkrankungen
DE60220145D1 (de) Verwendung eines mutterkrautextrakts zur regulierung der hautalterung
CA2286655A1 (en) Tissue decellularization
ATE233558T1 (de) Verwendung von strontiumsälze zur behandlung von arthrose
ATE253921T1 (de) Kombinationen aus calzium und vitamin d
WO2004060314A3 (en) Treatment of skin wounds using polyenylphosphatidylcholine and alkanolamines
DE69726245D1 (de) Befeuchtungsgerät zur Behandlung von Atemstillstand im Schlaf
NO20075065L (no) Anvendelse av isoflavonforbindelser til a behandle hjertesykdom
MX9306960A (es) Composiciones de extracto de corteza de roble, compositiones sinteticasrelacionadas, y metodo para su utilizacion.
ES2152072T3 (es) Compuesto nutritivo mejorado resultado de la maceracion de maiz y su procedimiento de obtencion.
DE59509848D1 (de) Kombinationspräparat zur anwendung bei immunologischen erkrankungen
ATE219073T1 (de) Benzopyran derivate mit leukotrien- antagonistischer wirkung
DE69635305D1 (de) Verwendung eines anti-interleukin-9 antikörpers zur herstellung eines medikamentes zur behandlung von asthma
ATE61524T1 (de) Verwendung von hyperoxygenierten oelen zur herstellung eines arzneimittells zur behandlung von herpes.
DE60206280D1 (de) Verwendung von extrakten aus ginkgo biloba zur herstellung eines medikaments zur behandlung von sarcopenia
ES2110550T3 (es) Tratamiento de la carne o del pescado.
ATE149832T1 (de) Verwendung von cromakalim/brl 38227 zur behandlung der überreaktivität der luftwege
ZA858672B (en) New use of 1,4-dihydropyridine derivatives and combinations thereof with calcitonins
ATE216842T1 (de) Hypoallergenischer instantbrei und verfahren zur herstellung
ATE155479T1 (de) Neue cytarabin-derivate, ihre herstellung und verwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties